We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
301
CALL
Intuitive Surgical
ISRG
$142B
– –
-90,000
Closed -$27.6M
LGVN
302
Longeveron
LGVN
$23.6M
– –
-6,712
Closed -$546K
LLY icon
303
Eli Lilly
LLY
$1.09T
– –
-65,922
Closed -$15.1M
LPCN icon
304
CALL
Lipocine
LPCN
$17M
– –
-11,765
Closed -$280K
LPCN icon
305
Lipocine
LPCN
$17M
– –
-3,220
Closed -$77K
LXRX icon
306
CALL
Lexicon Pharmaceuticals
LXRX
$1.05B
– –
-300,900
Closed -$1.38M
LXRX icon
307
PUT
Lexicon Pharmaceuticals
LXRX
$1.05B
– –
-63,300
Closed -$291K
MCRB icon
308
Seres Therapeutics
MCRB
$47.4M
– –
-1,500
Closed -$716K
MDT icon
309
PUT
Medtronic
MDT
$116B
– –
-500,000
Closed -$62.1M
MREO
310
Mereo BioPharma
MREO
$48.3M
– –
-196,570
Closed -$623K
NBIX icon
311
CALL
Neurocrine Biosciences
NBIX
$15.9B
– –
-47,300
Closed -$4.6M
NPCE icon
312
Neuropace
NPCE
$496M
– –
-229,264
Closed -$5.45M
NTLA icon
313
PUT
Intellia Therapeutics
NTLA
$1.69B
– –
-246,900
Closed -$40M
NVAX icon
314
Novavax
NVAX
$1.31B
– –
-10,000
Closed -$2.12M
ORGO icon
315
Organogenesis Holdings
ORGO
$233M
– –
-1,281,600
Closed -$19.9M
PFE icon
316
PUT
Pfizer
PFE
$150B
– –
-300,000
Closed -$11.7M
PROF
317
Profound Medical
PROF
$252M
– –
-644,273
Closed -$10.5M
PSNL icon
318
CALL
Personalis
PSNL
$1.52B
– –
-87,500
Closed -$2.21M
QGEN icon
319
PUT
Qiagen
QGEN
$8.88B
– –
-235,764
Closed -$12.1M
RCUS icon
320
CALL
Arcus Biosciences
RCUS
$3.69B
– –
-88,000
Closed -$2.42M
RCUS icon
321
PUT
Arcus Biosciences
RCUS
$3.69B
– –
-11,100
Closed -$305K
REGN icon
322
Regeneron Pharmaceuticals
REGN
$82.2B
– –
-10,000
Closed -$5.58M
RVTY icon
323
PUT
Revvity
RVTY
$13.2B
– –
-127,500
Closed -$19.7M
SYK icon
324
PUT
Stryker
SYK
$133B
– –
-50,000
Closed -$13M
TALK icon
325
Talkspace
TALK
$869M
– –
-1,205,869
Closed -$10M
10 11 12
13
14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.